Your browser doesn't support javascript.
loading
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience.
de Castro, Tiago; Jochheim, Leonie S; Bathon, Melanie; Welland, Sabrina; Scheiner, Bernhard; Shmanko, Kateryna; Roessler, Daniel; Ben Khaled, Najib; Jeschke, Matthias; Ludwig, Johannes M; Marquardt, Jens U; Weinmann, Arndt; Pinter, Matthias; Lange, Christian M; Vogel, Arndt; Saborowski, Anna.
Afiliação
  • de Castro T; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Jochheim LS; Department of Gastroenterology and Hepatology, Essen University Hospital, Essen, Germany.
  • Bathon M; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Welland S; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Scheiner B; Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Shmanko K; Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Roessler D; Department of Medicine II, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.
  • Ben Khaled N; Department of Medicine II, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.
  • Jeschke M; Department of Gastroenterology and Hepatology, Essen University Hospital, Essen, Germany.
  • Ludwig JM; Institute of Diagnostic and Interventional Radiology and Neuroradiology, Faculty of Medicine, Essen University Hospital, Essen, Germany.
  • Marquardt JU; Department of Medicine I, University Hospital Schleswig-Holstein, Lübeck, Germany.
  • Weinmann A; Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Pinter M; Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Lange CM; Department of Gastroenterology and Hepatology, Essen University Hospital, Essen, Germany.
  • Vogel A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany.
  • Saborowski A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Ther Adv Med Oncol ; 14: 17588359221080298, 2022.
Article em En | MEDLINE | ID: mdl-35251317
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article